Heringer Manoela, Souza Thiara Manuele A, Lima Monique da Rocha Q, Nunes Priscila Conrado G, Faria Nieli Rodrigues da C, de Bruycker-Nogueira Fernanda, Chouin-Carneiro Thaís, Nogueira Rita Maria R, Dos Santos Flavia Barreto
Viral Immunology Laboratory, Oswaldo Cruz Institute/FIOCRUZ, Av Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21045-360, Brazil.
Flavivirus Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
BMC Infect Dis. 2017 Jun 9;17(1):410. doi: 10.1186/s12879-017-2488-4.
Due to the populations' susceptibility, DENV-4 introduction in 2010 led to the occurrence of explosive epidemics in the following years in Brazil. In 2011, DENV-4 was identified in Rio de Janeiro (RJ) and it was prevalent in 2012 and 2013. Here, we aimed to characterize clinical, epidemiological and laboratorial aspects of DENV-4 cases after this serotype introduction in an endemic scenario.
Dengue suspected cases (n = 3727) were received and analyzed from January 2011 to December 2013, during outbreaks occurred in RJ, Brazil. Samples were submitted to virological, serological and molecular methods for case confirmation. DENV-4 cases (n = 705) were characterized according to the type of infection, disease severity and, viremia levels and NS1 antigenemia were accessed. Representative strains were partial sequenced for genotyping.
DENV-4 was identified in 44.2% (705/1593) of dengue positive cases, virus isolated in 48.7% of the cases. Anti-DENV IgM was detected in 39.4% of the cases, however an increased detection was observed in cases with ≥4 days of symptoms (57.0%). NS1 antigen was identified in 41.5% of DENV-4 cases however, after immune complexes dissociation, the detection significantly increased (87.6%). Females were more affected than males, so did children aged 11-15 years old. Primary cases were more frequently observed than secondary ones and most of them were classified as dengue. No differences on NS1 antigenemia and viraemia within the groups were observed. Despite the higher frequency of severe disease on individuals >65 years old, no differences were observed among the groups and type of infection. However, DENV-4 fatal cases were more frequent on secondary infections (57.1%). DENV-4 Genotype II was identified with a probable origin from Venezuela and Colombia.
It has been shown that laboratorial diagnosis is still a reliable tool for the disease surveillance, detecting and confirming emerging epidemics. Despite the occurrence of secondary infections, most DENV-4 cases presented a mild disease. As RJ is endemic for dengue, high rates of secondary infections would be expected. Despite the existence of two genotypes, only Genotype II was identified in our study.
由于人群易感性,2010年登革热4型(DENV-4)传入巴西后,在接下来的几年引发了大规模疫情。2011年,在里约热内卢(RJ)发现了DENV-4,2012年和2013年该病毒流行。在此,我们旨在描述在地方流行情况下引入该血清型后DENV-4病例的临床、流行病学和实验室特征。
2011年1月至2013年12月期间,在巴西RJ发生疫情期间,接收并分析了3727例登革热疑似病例。样本采用病毒学、血清学和分子方法进行病例确诊。根据感染类型、疾病严重程度对705例DENV-4病例进行特征描述,并检测病毒血症水平和NS1抗原血症。对代表性毒株进行部分测序以进行基因分型。
在1593例登革热阳性病例中,44.2%(705/1593)检测到DENV-4,48.7%的病例分离到病毒。39.4%的病例检测到抗DENV IgM,但症状出现≥4天的病例中检测率有所增加(57.0%)。41.5%的DENV-4病例检测到NS1抗原,但在免疫复合物解离后,检测率显著提高(87.6%)。女性比男性受影响更严重,11 - 15岁儿童也是如此。初发病例比继发病例更常见,且大多数被归类为登革热。各亚组间NS1抗原血症和病毒血症无差异。尽管65岁以上个体患重症疾病的频率较高,但各亚组和感染类型之间未观察到差异。然而,继发感染中DENV-4致死病例更为常见(57.1%)。鉴定出DENV-4基因型II,其可能起源于委内瑞拉和哥伦比亚。
研究表明,实验室诊断仍然是疾病监测、检测和确认新出现疫情的可靠工具。尽管存在继发感染,但大多数DENV-4病例病情较轻。由于RJ是登革热地方流行区,预计继发感染率较高。尽管存在两种基因型,但本研究仅鉴定出基因型II。